Press Conference Type
Session Type
Date Time

New analysis from the ECHO trial what this means for prevention and care for HIV, STIs and pregnancy

Nelly Mugo, Kenya Medical Research Institute (KEMRI), Kenya
An overview of the ECHO trial and its findings
Thesla Palanee-Phillips, Wits Reproductive Health and HIV Institute, South Africa
High HIV incidence among young women in South Africa: data from the ECHO trial
Jennifer Deese, FHI 360, United States
Risk of sexually transmitted infections among women randomized to DMPA-IM, the copper IUD, and levonorgestrel implant in the Evidence for Contraceptive Options and HIV Outcomes (ECHO) trial
Ivana Beesham, University of Witwatersrand, South Africa
Integrating oral PrEP delivery into a large HIV endpoint-driven clinical trial in Eastern and Southern Africa: the ECHO trial experience
Serena Koenig, Brigham and Women's Hospital, United States
Improved survival for people living with HIV, with and without tuberculosis, over time in Latin America
James Kiarie, WHO, Switzerland
Implications of new insights for policies and programmes